Omecamtiv Mecarbil and Its Effects on Cardiac Parameters in Heart Failure With Reduced Ejection Fraction (HFrEF). A Meta-Analysis of Randomized Controlled Trials

被引：0
|
作者：
Farooqui, Arafat
Bilal, Haris
Saleem, Naira
Uddin, Syed Mohammad Mazhar
Shetty, Vijay
Hollander, Gerald
Shani, Jacob
机构：
来源：
CIRCULATION | 2022年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10050
引用
收藏
页数：2
相关论文
共 50 条
  • [41] What is the Efficacy of New Therapies in Black Patients With Heart Failure and a Reduced Ejection Fraction? A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Pandey, Arjun K.
    Dhingra, Nitish K.
    Pandey, Avinash K.
    Puar, Pankaj
    Ahmed, Shamon
    Verma, Raj
    Mazer, David
    Butler, Javed
    Badiwala, Mitesh V.
    Yau, Terrence
    Yanagawa, Bobby
    Bhatt, Deepak L.
    Verma, Subodh
    CIRCULATION, 2022, 146
  • [42] Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials
    Coats, Andrew J. S.
    Abraham, William T.
    Zile, Michael R.
    Lindenfeld, Joann A.
    Weaver, Fred A.
    Fudim, Marat
    Bauersachs, Johann
    Duval, Sue
    Galle, Elizabeth
    Zannad, Faiez
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (09) : 1665 - 1673
  • [43] Effect of the Cardiac Myosin Activator Omecamtiv Mecarbil on Risk of Ventricular Arrhythmias in Heart Failure with Reduced Ejection Fraction: the GALACTIC-HF Trial
    Foa, Alberto
    Vaduganathan, Muthiah
    Claggett, Brian
    Mani, Govini
    Diaz, Rafael
    Malik, Fady
    Heitner, Stephen
    Felker, Gary
    Metra, Marco
    McMurray, John
    Teerlink, John
    Solomon, Scott
    CIRCULATION, 2024, 150
  • [44] Comparative cardiovascular outcomes of novel drugs as an addition to conventional triple therapy for heart failure with reduced ejection fraction (HFrEF): a network meta-analysis of randomised controlled trials
    Suebsaicharoen, Thanakit
    Chunekamrai, Puri
    Yingchoncharoen, Teerapat
    Tansawet, Amarit
    Issarawattana, Thanaphruet
    Numthavaj, Pawin
    Thakkinstian, Ammarin
    OPEN HEART, 2023, 10 (02):
  • [45] EFFECTS OF SPIRONOLACTONE ON THE PROGNOSIS OF HEART FAILURE PATIENTS WITH PRESERVED EJECTION FRACTION: A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS
    Xiang, Yajie
    Huang, Wei
    Yang, Yunjing
    Wang, Stephen Yishu
    Shi, Wenhai
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 702 - 702
  • [46] Effects of drug treatment on clinical outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials
    Zheng, S. L.
    Chan, F. T.
    Nabeebaccus, A. A.
    Shah, A. M.
    McDonagh, T.
    Okonko, D. O.
    Ayis, S.
    EUROPEAN HEART JOURNAL, 2017, 38 : 904 - 905
  • [47] Supervised exercise training in heart failure with preserved ejection fraction: A systematic review and meta-analysis of randomized controlled trials
    Sebastian, Sneha Annie
    Padda, Inderbir
    Johal, Gurpreet
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (04)
  • [48] Eplerenone vs Spironolactone and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction: A Meta-Analysis
    Elshahat, Ahmed
    Abdelaziz, Ahmed
    Mansour, Ahmed
    Kuno, Toshiki
    Mentz, Robert J.
    Slipczuk, Leandro
    Lavie, Carl J.
    MAYO CLINIC PROCEEDINGS, 2025, 100 (03) : 572 - 576
  • [49] Effect of beta-blockers on heart failure severity in patients with heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials
    Fukuta, Hidekatsu
    Goto, Toshihiko
    Wakami, Kazuaki
    Kamiya, Takeshi
    Ohte, Nobuyuki
    HEART FAILURE REVIEWS, 2021, 26 (01) : 165 - 171
  • [50] Safety and efficacy of renal denervation in patients with heart failure with reduced ejection fraction (HFrEF): A systematic review and meta-analysis
    Xia, Zhiqiu
    Han, Li
    Pellegrino, Peter R.
    Schiller, Alicia M.
    Harrold, Logan D.
    Lobato, Robert L.
    Lisco, Steven J.
    Zucker, Irving H.
    Wang, Han-Jun
    HELIYON, 2022, 8 (01)
12345